ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
4,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
6,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
7,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
7,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
7,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
8,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
9,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
11,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,4,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
12,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
13,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
13,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
14,1,Chemical burn of skin,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
14,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
14,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
15,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
15,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
15,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,1,Hypotrichosis,Alopecias,Skin appendage conditions,Skin,N
17,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
18,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
19,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
20,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
21,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
22,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
22,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
22,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
23,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
24,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
24,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
24,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
24,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
24,5,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
25,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
25,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
26,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
27,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
27,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
27,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
27,5,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
28,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
29,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
30,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
31,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
32,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
32,2,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
33,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
33,3,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
33,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
33,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,1,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
34,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
35,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
35,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
36,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
36,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
36,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
36,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
36,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
37,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
37,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
37,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
37,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
38,1,Axillary mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
38,2,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
38,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
38,5,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
39,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
39,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
39,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
39,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
39,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
40,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
40,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
40,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
41,1,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
41,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
42,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
42,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
42,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
42,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
43,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
43,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
44,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
44,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
44,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
45,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
46,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
46,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
46,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
46,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
47,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
47,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
48,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
49,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
49,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
49,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
50,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
51,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
51,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
51,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
51,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
52,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Axillary pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
53,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
53,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
53,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
53,5,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
53,6,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
53,7,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
54,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
54,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
54,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
55,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
55,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
57,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
58,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
59,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
61,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
